PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Clinical trials for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One pill to rule them all? new combo therapy for PAH shows promise
Disease control CompletedThis study tested whether a single pill containing two drugs (macitentan and tadalafil) works better for pulmonary arterial hypertension (PAH) than taking either drug alone. 187 adults with PAH took part. The goal was to see if the combination pill improves blood flow in the lung…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated May 26, 2026 05:26 UTC
-
Breathe easy: slow breathing may ease PAH symptoms
Symptom relief CompletedThis study looked at whether doing slow-paced breathing exercises at home can help people with pulmonary arterial hypertension (PAH) manage symptoms like shortness of breath, fatigue, and poor sleep. Forty-two adults with stable PAH took part. The goal was to see if this simple t…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated May 26, 2026 05:22 UTC
-
Ultrasound score may sharpen risk prediction in rare lung disease
Knowledge-focused CompletedThis study looked at whether a special ultrasound score, called VExUS, can help doctors better understand risk in people with pulmonary arterial hypertension (PAH), a rare and serious lung condition. Researchers compared the VExUS score with standard tests like heart catheterizat…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated May 26, 2026 05:32 UTC